Literature DB >> 34052054

Racial disparities in use of non-emergency outpatient care by Medicaid-eligible adults after release from prison: Wisconsin, 2015-2017.

Karli R Hochstatter1, Wajiha Z Akhtar2, Nabila El-Bassel3, Ryan P Westergaard4, Marguerite E Burns5.   

Abstract

BACKGROUND: Black individuals with substance use disorders (SUD) are less likely to receive effective treatment and more likely to be incarcerated compared to White individuals. Despite this, research documenting racial disparities in healthcare use among people with SUD releasing from prison is limited.
OBJECTIVES: The goals of this study are to: 1) assess racial disparities in Medicaid enrollment among individuals released from prison with a history of substance use; and 2) characterize racial disparities in outpatient service use, emergency department (ED) use, and receipt of medication for opioid use disorder (MOUD) among those who do enroll in Medicaid.
METHODS: This study included individuals with a history of substance use that were released from Wisconsin state correctional facilities from April 2015 through June 2017. Medicaid enrollment and claims data were analyzed to compare healthcare utilization 6 months post-release between individuals identifying as Black, White, or other races. The total sample included 15,621 prison releases among 14,400 unique persons with a history of substance abuse.
RESULTS: Among the 15,621 prison releases, 10,836 (69.4%) were enrolled in Medicaid in the month of release. The proportion of prison releases among individuals of other races who enrolled in Medicaid (506/934, 54.2%) was significantly lower than the proportion among Black individuals (3679/5306, 69.3%) and White individuals (6651/9381, 70.9%). Among the subset of 7685 releases enrolled in Medicaid for 6 months post-release, 5040 (65.6%) had an outpatient visit within 6 months; 73.9% of White, 51.3% of Black, and 66.9% of other individuals. Relative to White individuals, Black individuals were 0.324 times less likely (P < 0.001) and individuals of other races were 0.591 times less likely (P = 0.004) to have an outpatient visit. Of the 7685 releases, 1016 (13.2%) had an ED visit within 6 months; 12.0% of White, 13.8% of Black and 25.1% of other individuals. Relative to White individuals, Black individuals were 1.23 times more likely (P = 0.019) and individuals of other races were 2.64 times more likely (P < 0.001) to have an ED visit. Black individuals were 0.100 times less likely (P < 0.001) and individuals of other races were 0.435 times less likely (P = 0.016) to receive MOUD post-release compared to White individuals.
CONCLUSIONS: Black adults with a history of substance use are significantly less likely than White adults to use non-emergency outpatient services after release from incarceration. Improving equitable access to outpatient services is needed to reduce health disparities across racial groups.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Healthcare utilization; Medication for opioid use disorder; Post-release; Racial disparities; Substance abuse

Mesh:

Year:  2021        PMID: 34052054      PMCID: PMC8197748          DOI: 10.1016/j.jsat.2021.108484

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  24 in total

1.  Unequal treatment: confronting racial and ethnic disparities in health care.

Authors:  Alan Nelson
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

2.  Examining racial and ethnic disparities in site of usual source of care.

Authors:  Darrell J Gaskin; Jose J Arbelaez; Jorielle R Brown; Hanno Petras; Fernando A Wagner; Lisa A Cooper
Journal:  J Natl Med Assoc       Date:  2007-01       Impact factor: 1.798

3.  Racial and gender differences in use of procedures for black and white hospitalized adults.

Authors:  D R Harris; R Andrews; A Elixhauser
Journal:  Ethn Dis       Date:  1997 Spring-Summer       Impact factor: 1.847

4.  A large-scale analysis of racial disparities in police stops across the United States.

Authors:  Emma Pierson; Camelia Simoiu; Jan Overgoor; Sam Corbett-Davies; Daniel Jenson; Amy Shoemaker; Vignesh Ramachandran; Phoebe Barghouty; Cheryl Phillips; Ravi Shroff; Sharad Goel
Journal:  Nat Hum Behav       Date:  2020-05-04

5.  Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City.

Authors:  Helena Hansen; Carole Siegel; Joseph Wanderling; Danae DiRocco
Journal:  Drug Alcohol Depend       Date:  2016-05-04       Impact factor: 4.492

6.  Performance of Risk-Based and Birth-Cohort Strategies for Identifying Hepatitis C Virus Infection Among People Entering Prison, Wisconsin, 2014.

Authors:  Lauren J Stockman; James Greer; Ryan Holzmacher; Beth Dittmann; Scott A Hoftiezer; Lori E Alsum; Audrey Prieve; Ryan P Westergaard; Sheila M Guilfoyle; James M Vergeront
Journal:  Public Health Rep       Date:  2016 Jul-Aug       Impact factor: 2.792

7.  Medicaid Enrollment among Prison Inmates in a Non-expansion State: Exploring Predisposing, Enabling, and Need Factors Related to Enrollment Pre-incarceration and Post-Release.

Authors:  Catherine A Grodensky; David L Rosen; Colleen M Blue; Anna R Miller; Steve Bradley-Bull; Wizdom A Powell; Marisa E Domino; Carol E Golin; David A Wohl
Journal:  J Urban Health       Date:  2018-08       Impact factor: 3.671

8.  Perceived Stigma in Health Care Settings and the Physical and Mental Health of People of Color in the United States.

Authors:  Henna Budhwani; Prabal De
Journal:  Health Equity       Date:  2019-03-21

9.  Factors influencing emergency department preference for access to healthcare.

Authors:  Lindsay E Brown; Ryan Burton; Brian Hixon; Manasi Kakade; Parul Bhagalia; Catherine Vick; Andrew Edwards; Mary T Hawn
Journal:  West J Emerg Med       Date:  2012-11

10.  Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012.

Authors:  Jon E Zibbell; Kashif Iqbal; Rajiv C Patel; Anil Suryaprasad; Kathy J Sanders; Loretta Moore-Moravian; Jamie Serrecchia; Steven Blankenship; John W Ward; Deborah Holtzman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-05-08       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.